Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
midazolam
midazolam
Brand names: Versed
| Form | Strength |
|---|---|
| SOLUTION, INJECTABLE | 1 mg/mL; 1 mg/mL-NaCl 0.9%; 1 mg/mL preservative-free; 5 mg/mL; 5 mg/mL preservative-free |
| SYRUP, ORAL | 2 mg/mL |
Last updated: Nov. 30, 2021
- High Alert: CAUTION: See High-Alert Medication Policy
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Black Box Warning: Individualize dose
Class IV
Midazolam may be given via hypodermoclysis (HDC/subcutaneous infusion). See Procedure 904.4991
Use in a ventilated Critical Care patient: See 901.5008
Use in mechanically ventilated patients, See the Pain, Agitation and Delirium Protocol (aka "PAD") Protocol 901.6008
For pediatric long term sedation weaning: See Protocol 912.6016
Status Epilepticus Protocol for Adult Patients: See Protocol 900.6016
Mucosal Atomization Device administration of IN Midazolam in Epilepsy Monitoring Unit (EMU), See 900.1412
Infusion Concentrations and Ranges:
Adult General Titration Ranges and Administration (weight based dosing): See Handout (updated Aug 2016)